BR0110129A - Composição farmacêutica - Google Patents

Composição farmacêutica

Info

Publication number
BR0110129A
BR0110129A BR0110129-3A BR0110129A BR0110129A BR 0110129 A BR0110129 A BR 0110129A BR 0110129 A BR0110129 A BR 0110129A BR 0110129 A BR0110129 A BR 0110129A
Authority
BR
Brazil
Prior art keywords
pharmaceutical composition
release phase
paracetamol
unique
pharmacokinetic properties
Prior art date
Application number
BR0110129-3A
Other languages
English (en)
Inventor
Yue Shing Chan
Timothy James Grattan
Bounkhiene Sengmanee
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9890126&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR0110129(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of BR0110129A publication Critical patent/BR0110129A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Confectionery (AREA)

Abstract

"COMPOSIçãO FARMACêUTICA". Uma composição farmacêutica compreendendo uma fase de liberação imediata e uma fase de liberação prolongada de paracetamol é descrita que tem um perfil de dissolução in vitro singular resultando em propriedades farmacocinéticas vantajosas.
BR0110129-3A 2000-04-19 2001-04-12 Composição farmacêutica BR0110129A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0009522.4A GB0009522D0 (en) 2000-04-19 2000-04-19 Composition
PCT/EP2001/004302 WO2001080834A1 (en) 2000-04-19 2001-04-12 Composition

Publications (1)

Publication Number Publication Date
BR0110129A true BR0110129A (pt) 2002-12-31

Family

ID=9890126

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0110129-3A BR0110129A (pt) 2000-04-19 2001-04-12 Composição farmacêutica

Country Status (25)

Country Link
US (2) US7943170B2 (pt)
EP (1) EP1274402B1 (pt)
JP (1) JP2003531165A (pt)
KR (1) KR100845660B1 (pt)
CN (1) CN100335046C (pt)
AT (1) ATE438388T1 (pt)
AU (2) AU2001260212C1 (pt)
BR (1) BR0110129A (pt)
CA (1) CA2406373C (pt)
CO (1) CO5280073A1 (pt)
CY (1) CY1109483T1 (pt)
CZ (1) CZ303275B6 (pt)
DE (1) DE60139462D1 (pt)
DK (1) DK1274402T3 (pt)
EA (1) EA006103B1 (pt)
ES (1) ES2329971T3 (pt)
GB (1) GB0009522D0 (pt)
HK (1) HK1053601A1 (pt)
HU (1) HU230033B1 (pt)
MX (1) MXPA02010347A (pt)
NZ (1) NZ521799A (pt)
TW (1) TWI282286B (pt)
UA (1) UA76417C2 (pt)
WO (1) WO2001080834A1 (pt)
ZA (1) ZA200208084B (pt)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0009522D0 (en) * 2000-04-19 2000-06-07 Smithkline Beecham Plc Composition
TWI319713B (en) 2002-10-25 2010-01-21 Sustained-release tramadol formulations with 24-hour efficacy
US8487002B2 (en) 2002-10-25 2013-07-16 Paladin Labs Inc. Controlled-release compositions
US20040186180A1 (en) * 2003-03-21 2004-09-23 Gelotte Cathy K. Non-steroidal anti-inflammatory drug dosing regimen
CN100348974C (zh) * 2003-09-30 2007-11-14 北京东方凯恩医药科技有限公司 一种药物组合物的检测方法
US20050095299A1 (en) * 2003-10-30 2005-05-05 Wynn David W. Controlled release analgesic suspensions
PL1931346T3 (pl) 2005-09-09 2013-01-31 Angelini Labopharm Llc Kompozycja trazodonu do podawania raz na dobę
US20080057122A1 (en) * 2006-08-31 2008-03-06 Aaipharma Inc. Acetaminophen pharmaceutical compositions
EP2203166B1 (en) 2007-10-16 2015-05-06 Paladin Labs Inc. Bilayer composition for the sustained release of acetaminophen and tramadol
AU2008338207A1 (en) 2007-12-17 2009-06-25 Labopharm (Barbados) Limited Misuse preventative, controlled release formulation
US9226907B2 (en) 2008-02-01 2016-01-05 Abbvie Inc. Extended release hydrocodone acetaminophen and related methods and uses thereof
AU2009223061B2 (en) 2008-03-11 2014-10-09 Depomed Inc. Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic
US8372432B2 (en) 2008-03-11 2013-02-12 Depomed, Inc. Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic
CA2746888C (en) 2008-12-16 2015-05-12 Labopharm (Barbados) Limited Misuse preventative, controlled release formulation
CA2752233C (en) * 2009-02-13 2017-01-03 Romark Laboratories L.C. Controlled release pharmaceutical formulations of nitazoxanide
KR20120059582A (ko) * 2009-08-31 2012-06-08 데포메드 인코퍼레이티드 아세트아미노펜의 속방성 및 서방성을 위한 위 체류 약제학적 조성물
US9198861B2 (en) 2009-12-22 2015-12-01 Mallinckrodt Llc Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans
US8597681B2 (en) 2009-12-22 2013-12-03 Mallinckrodt Llc Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans
SG194605A1 (en) * 2011-05-06 2013-12-30 Glaxosmithkline Llc Sustained release paracetamol formulations
US8741885B1 (en) 2011-05-17 2014-06-03 Mallinckrodt Llc Gastric retentive extended release pharmaceutical compositions
US8858963B1 (en) 2011-05-17 2014-10-14 Mallinckrodt Llc Tamper resistant composition comprising hydrocodone and acetaminophen for rapid onset and extended duration of analgesia
US8658631B1 (en) 2011-05-17 2014-02-25 Mallinckrodt Llc Combination composition comprising oxycodone and acetaminophen for rapid onset and extended duration of analgesia
US20140206740A1 (en) * 2011-07-30 2014-07-24 Neurovance, Inc. Use Of (1R,5S)-(+)-(Napthalen-2-yl)-3-Azabicyclo[3.1.0]Hexane In The Treatment Of Conditions Affected By Monoamine Neurotransmitters
WO2014063101A1 (en) * 2012-10-18 2014-04-24 Abbvie Inc. Formulations of pyrimidinedione derivative compounds
WO2016042570A1 (en) * 2014-09-16 2016-03-24 Suresh Pareek Extended release formulation of acetaminophen
CA3016852C (en) 2016-03-09 2021-03-23 Nls-1 Pharma Ag A mazindol ir/sr multilayer tablet and its use for the treatment of attention deficit/hyperactivity disorder (adhd)

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2058562B (en) * 1979-09-14 1983-11-30 Beecham Group Ltd Pharmaceutical compositions containing paracetamol and ascorbic acid
US4786503A (en) * 1987-04-06 1988-11-22 Alza Corporation Dosage form comprising parallel lamine
US4820522A (en) * 1987-07-27 1989-04-11 Mcneilab, Inc. Oral sustained release acetaminophen formulation and process
EP0418596A3 (en) * 1989-09-21 1991-10-23 American Cyanamid Company Controlled release pharmaceutical compositions from spherical granules in tabletted oral dosage unit form
US5009895A (en) * 1990-02-02 1991-04-23 Merck & Co., Inc. Sustained release with high and low viscosity HPMC
US5900425A (en) * 1995-05-02 1999-05-04 Bayer Aktiengesellschaft Pharmaceutical preparations having controlled release of active compound and processes for their preparation
US5773031A (en) * 1996-02-27 1998-06-30 L. Perrigo Company Acetaminophen sustained-release formulation
BE1011045A3 (fr) * 1997-03-14 1999-04-06 Ucb Sa Compositions pharmaceutiques pour la liberation controlee de substances actives.
FR2766708B1 (fr) 1997-07-30 2000-05-05 Galenix Dev Composition contenant de l'hydroxypropylcellulose, de l'hydroxypropylmethylcellulose et/ou de l'ethylcellullose a titre d'agents desintegrants, et procede d'obtention
US5945123A (en) * 1998-04-02 1999-08-31 K-V Pharmaceutical Company Maximizing effectiveness of substances used to improve health and well being
US6254891B1 (en) 1998-09-03 2001-07-03 Ascent Pediatrics, Inc. Extended release acetaminophen
US6126967A (en) 1998-09-03 2000-10-03 Ascent Pediatrics Extended release acetaminophen particles
GB0009522D0 (en) * 2000-04-19 2000-06-07 Smithkline Beecham Plc Composition
US7897172B2 (en) * 2004-05-18 2011-03-01 L. Perrigo Company Tablets exhibiting reduced drug release variability

Also Published As

Publication number Publication date
MXPA02010347A (es) 2003-04-25
PL358123A1 (en) 2004-08-09
TWI282286B (en) 2007-06-11
HU230033B1 (hu) 2015-05-28
DK1274402T3 (da) 2009-11-16
CY1109483T1 (el) 2014-08-13
NZ521799A (en) 2004-12-24
EP1274402A1 (en) 2003-01-15
CZ303275B6 (cs) 2012-07-11
US20110177168A1 (en) 2011-07-21
DE60139462D1 (de) 2009-09-17
WO2001080834A1 (en) 2001-11-01
HUP0300698A2 (hu) 2003-07-28
KR100845660B1 (ko) 2008-07-10
ZA200208084B (en) 2003-10-08
ES2329971T3 (es) 2009-12-03
US20040202716A1 (en) 2004-10-14
JP2003531165A (ja) 2003-10-21
AU2001260212C1 (en) 2020-07-16
AU6021201A (en) 2001-11-07
CO5280073A1 (es) 2003-05-30
CZ20023470A3 (cs) 2003-03-12
EP1274402B1 (en) 2009-08-05
KR20030009440A (ko) 2003-01-29
GB0009522D0 (en) 2000-06-07
UA76417C2 (en) 2006-08-15
AU2001260212B2 (en) 2006-09-21
CA2406373A1 (en) 2001-11-01
ATE438388T1 (de) 2009-08-15
EA200200954A1 (ru) 2003-04-24
CN100335046C (zh) 2007-09-05
HUP0300698A3 (en) 2004-09-28
EA006103B1 (ru) 2005-08-25
HK1053601A1 (en) 2003-10-31
CA2406373C (en) 2010-06-29
US7943170B2 (en) 2011-05-17
CN1426298A (zh) 2003-06-25

Similar Documents

Publication Publication Date Title
BR0110129A (pt) Composição farmacêutica
BR0107869A (pt) Composições farmacêuticas eletrogiradas
BR0001515A (pt) Composições de espuma estáveis
CY2009015I2 (el) Φαρμακευτικος συνδυασμος αιθινυλεστραδιολης και δροπιρενονης για χρηση ως αντισυλληπτικο
FR2834212B1 (fr) Utilisation d'une poudre a liberation immediate dans des compositions pharmaceutiques et nutraceutiques
GB2365772A (en) Factor
ES2187201T3 (es) Empleo de esteroles y de esterolesteres a nanoescala.
TWI235068B (en) Sustained-release pharmaceutical composition
BR9811803A (pt) Comprido multiparticular aperfeiçoado de dissolução rápida
BR0112054A (pt) Composição formadora de micelas, e métodos para a administração e a proteção de um agente terapêutico
CY1108918T1 (el) Φαρμακευτικοι συνδυασμοι οξυκωδονης και ναλοξονης
DE60143393D1 (de) Modifizierte formen pharmazeutisch aktiver agenzien und verwendungen dafür
AR022008A1 (es) Una composicion de liberacion controlada de galantamina, un proceso para la preparacion de la misma, y el uso de dicha composicion para la preparacion de un medicamento
ME00520B (me) Levodop/karbidop/entakapon farmaceutski preparat
BR9804802A (pt) Composi-Æo de libera-Æo sustentada de drogas encapsuladas em micropoarticulas de cido hialuronico
BR0009770A (pt) Derivados de bisindóis indigóides capazes de penetrarem na membrana de células, formulação farmacêutica e utilização da mesma
BR0209283A (pt) Método para a fabricação de uma composição farmacêutica de baixa dosagem tendo distribuição e potência de droga uniforme
BR0313428A (pt) Composições farmacêuticas de drogas semi-ordenados e polìmeros
BR9809571A (pt) Composição medicinal e processo para produzì-la
BR0113165A (pt) Derivados de 4-pirimidinamina, composições farmacêuticas e métodos relacionados
ITMI20010957A0 (it) Derivati dell'aoe-emodina e loro impiego nel trattamento di patologieneoplastiche
PL360289A1 (en) Arylpiperazine derivatives and their use as psychotropic agents
BR0206960A (pt) Composição farmacêutica oral, e, uso de um polìmero de ftalato de hidroxipropilmetilcelulose
ATE397447T1 (de) Feste paroxetin enthaltende zubereitungen
BR0001144B1 (pt) Composicão farmacêutica de diclofenaco à base de vitamina-e, papaína e hialuronidase

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O, 13, 24 E 25 DA LPI.

B12B Appeal against refusal [chapter 12.2 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B25B Requested transfer of rights rejected

Owner name: SMITHKLINE BEECHAM P.L.C. (GB)

B25E Requested change of name of applicant rejected

Owner name: SMITHKLINE BEECHAM P.L.C. (GB)

B25B Requested transfer of rights rejected

Owner name: SMITHKLINE BEECHAM P.L.C. (GB)

B25E Requested change of name of applicant rejected

Owner name: SMITHKLINE BEECHAM P.L.C. (GB)